Business
Replacement - 1st Quarter Results
Replacement - 1st Quarter Results.
About this update from Integrated Diagnostics Holdings Plc
[{"type":"text","content":"\n \nRNS Number : 1297Z Integrated Diagnostics Holdings PLC 15 May 2019 \n\nIntegrated Diagnostics Holdings Plc\nReplacement 1Q2019 Results Update\nWednesday, 15 May 2019\n \nFollowing the announcement this morning '1st Quarter Results', RNS Number: 0374Z, an error on the financials relating to the Key Performance Indicators and Revenue Analysis: Contribution by Patient Segment has been highlighted. Therefore the results have been updated and superseded as stated below. \n \nIntegrated Diagnostics Holdings Plc records strong revenue growth and robust profitability in the first quarter of 2019 \n \n(London) Integrated Diagnostics Holdings (\"IDH,\" \"the Group,\" or \"the Company\"), a leading consumer healthcare company with operations in Egypt, Jordan, Sudan and Nigeria, released today unaudited highlights of its financial and operational performance in the first quarter of 20191, reporting unaudited net profit of EGP 122 million on total unaudited revenues of EGP 546 million.\n \nResults\n\n\n\n\n \n\n\n1Q2019\n\n\n1Q2018\n\n\n change\n\n\n\n\nRevenues\n\n\n546\n\n\n446 \n\n\n22%\n\n\n\n\nCost of Sales\n\n\n281\n\n\n229\n\n\n23%\n\n\n\n\nGross Profit\n\n\n265\n\n\n217\n\n\n22%\n\n\n\n\nGross Profit Margin\n\n\n49%\n\n\n49%\n\n\n-\n\n\n\n\nOperating Profit\n\n\n197\n\n\n 150 \n\n\n32%\n\n\n\n\nEBITDA2\n\n\n236\n\n\n167 \n\n\n42%\n\n\n\n\nEBITDA Margin\n\n\n43%\n\n\n37%\n\n\n6 pts \n\n\n\n\nNet Profit\n\n\n122\n\n\n110\n\n\n11%\n\n\n\n\nNet Profit Margin \n\n\n22%\n\n\n25%\n\n\n(3 pts) \n\n\n\n\nCash Balance\n\n\n763\n\n\n664\n\n\n15%\n\n\n\n\n \n1By the terms regulating the company's listing on the LSE, IDH is required to release audited financials at the half- and full-year marks. Management and the Board of Directors have committed to providing performance updates in the first and third quarters as an outgrowth of the Company's commitment to transparency. All figures in this update are accordingly unaudited and provided from Management accounts. \n \n2EBITDA is calculated as operating profit plus depreciation and amortization.\n \nFinancial Highlights\n \n· Revenue grew 22% to EGP 546 million in 1Q2019 on account of higher patient and test volumes. Egypt delivered a strong 27% increase in revenue which helped compensa...